E617 20 (Opana ER 20 mg)
Generic Name: oxymorphone
Pill with imprint E617 20 is Green, Eight-sided and has been identified as Opana ER 20 mg. It is supplied by Endo Pharmaceuticals Inc..
Opana ER is used in the treatment of pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Opana ER 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for E617 20
Opana ER
- Generic Name
- oxymorphone
- Imprint
- E617 20
- Strength
- 20 mg
- Color
- Green
- Size
- 8.00 mm
- Shape
- Eight-sided
- Availability
- Prescription only
- Drug Class
- Narcotic analgesics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Endo Pharmaceuticals Inc.
- National Drug Code (NDC)
- 63481-0617
- Inactive Ingredients
-
hypromelloses,
methylparaben,
sodium stearyl fumarate,
titanium dioxide,
triacetin,
polyethylene glycol,
polysorbate 80,
FD&C Blue No. 1,
FD&C Yellow No. 6,
D&C Yellow No. 10
Note: Inactive ingredients may vary.
Submitted by: Drugs.com
More about Opana ER (oxymorphone)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- 85 Reviews
- Drug class: narcotic analgesics
- FDA Alerts (2)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.